|
1
|
Harbeck N and Gnant M: Breast cancer.
Lancet. 18:1134–1150. 2017. View Article : Google Scholar
|
|
2
|
Britt KL, Cuzick J and Phillips KA: Key
steps for effective breast cancer prevention. Nat Rev Cancer.
20:417–436. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
McGuire A, Brown JA, Malone C, McLaughlin
R and Kerin MJ: Effects of age on the detection and management of
breast cancer. Cancers (Basel). 7:908–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Heer E, Harper A, Escandor N, Sung H,
McCormack V and Fidler-Benaoudia MM: Global burden and trends in
premenopausal and postmenopausal breast cancer: A population-based
study. Lancet Glob Health. 8:e1027–e1037. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Anastasiadi Z, Lianos GD, Ignatiadou E,
Harissis HV and Mitsis M: Breast cancer in young Women: An
overview. Updates Surg. 69:313–317. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li Q, Liu J, Jiang Z and Liu Q: CSCO
breast cancer guideline: Precise, economical and oriental. Sci
China Life Sci. 63:1–3. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Winters S, Martin C, Murphy D and Shokar
NK: Breast cancer epidemiology, prevention, and screening. Prog Mol
Biol Transl Sci. 151:1–32. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Galan JA and Avruch J: MST1/MST2 Protein
Kinases: Regulation and physiologic roles. Biochemistry.
55:5507–5519. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hui OY, Zhou EX and Wang H: Mst1-Hippo
pathway triggers breast cancer apoptosis via inducing mitochondrial
fragmentation in a manner dependent on JNK-Drp1 axis. Onco Targets
Ther. 12:1147–1159. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Harvey KF, Zhang X and Thomas DM: The
Hippo pathway and human cancer. Nat Rev Cancer. 13:246–257. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hong AW, Meng Z and Guan KL: The Hippo
pathway in intestinal regeneration and disease. Nat Rev
Gastroenterol Hepatol. 13:324–337. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Torres-Bacete J, Delgado-Martin C,
Gomez-Moreira C, Simizu S and Rodríguez-Fernández JL: The mammalian
sterile 20-like 1 kinase controls selective CCR7-dependent
functions in human dendritic cells. J Immunol. 195:973–81. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang M, Zhang L, Hu J, Lin J, Wang T,
Duan Y, Man W, Feng J, Sun L, Jia H, et al: MST1 coordinately
regulates autophagy and apoptosis in diabetic cardiomyopathy in
mice. Diabetologia. 59:2435–2447. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao WB, Lu Q, Nguyen MN, Su Y, Ziemann M,
Wang LN, Kiriazis H, Puthalakath H, Sadoshima J, Hu HY and Du XJ:
Stimulation of β-adrenoceptors up-regulates cardiac expression of
galectin-3 and BIM through the hippo signalling pathway. Br J
Pharmacol. 176:2465–2481. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Singh A, Ramesh S, Cibi DM, Yun LS, Li J,
Li L, Manderfield LJ, Olson EN, Epstein JA and Singh MK: Hippo
signaling mediators yap and taz are required in the epicardium for
coronary vascµl ature development. Cell Rep. 15:1384–1393. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu FX, Zhao B and Guan KL: Hippo pathway
in organ size control, tissue homeostasis, and cancer. Cell.
163:811–828. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nallet-Staub F, Marsaud V, Li L, Gilbert
C, Dodier S, Bataille V, Sudol M, Herlyn M and Mauviel A:
Pro-invasive activity of the Hippo pathway effectors YAP and TAZ in
cutaneous melanoma. J Invest Dermatol. 134:123–132. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
He M, Zhou Z, Shah AA, Hong Y, Chen Q and
Wan Y: New insights into posttranslational modifications of Hippo
pathway in carcinogenesis and therapeutics. Cell Div. 11:42016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vincent-Mistiaen Z, Elbediwy A, Vanyai H,
Cotton J, Stamp G, Nye E, Spencer-Dene B, Thomas GJ, Mao J and
Thompson B: YAP drives cutaneous squamous cell carcinoma formation
and progression. Elife. 7:e333042018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Maugeri-Saccà M and De Maria R: Hippo
pathway and breast cancer stem cells. Crit Rev Oncol Hematol.
99:115–122. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rodriguez D, Ramkairsingh M, Lin X, Kapoor
A, Major P and Tang D: The central contributions of breast cancer
stem cells in developing resistance to endocrine therapy in
estrogen receptor (ER)-positive breast cancer. Cancers (Basel).
11:10282019. View Article : Google Scholar
|
|
22
|
Cortes E, Lachowski D, Rice A, Thorpe SD,
Robinson B, Yeldag G, Lee DA, Ghemtio L, Rombouts K and Del Río
Hernández AE: Tamoxifen mechanically deactivates hepatic stellate
cells via the G protein-coupled estrogen receptor. Oncogene.
38:2910–2922. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kolak A, Kamińska M, Sygit K, Budny A,
Surdyka D, Kukiełka-Budny B and Burdan F: Primary and secondary
prevention of breast cancer. Ann Agric Environ Med. 24:549–553.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hosonaga M, Saya H and Arima Y: Molecular
and cellular mechanisms underlying brain metastasis of breast
cancer. Cancer Metastasis Rev. 39:711–720. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics. 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
McDonald ES, Clark AS, Tchou J, Zhang P
and Freedman GM: Clinical diagnosis and management of breast
cancer. J Nucl Med. 57 (Suppl 1):9S–16S. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim MK, Jang JW and Bae SC: DNA binding
partners of YAP/TAZ. BMB Rep. 51:126–133. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
He Z, Zhao TT, Jin F, Li JG, Xu YY, Dong
HT, Liu Q, Xing P, Zhu GL, Xu H and Miao ZF: Downregulation of
RASSF6 promotes breast cancer growth and chemoresistance through
regulation of Hippo signaling. Biochem Biophys Res Commun.
503:2340–2347. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li JA, Kuang T, Pu N, Fang Y, Han X, Zhang
L, Xu X, Wu W, Wang D, Lou W and Rong Y: TRAF6 Regulates YAP
signaling by promoting the ubiquitination and degradation of MST1
in pancreatic cancer. Clin Exp Med. 19:211–218. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lin XY, Cai FF, Wang MH, Pan X, Wang F,
Cai L, Cui RR, Chen S and Biskup E: Mammalian sterile 20-like
kinase 1 expression and its prognostic significance in patients
with breast cancer. Oncol Lett. 14:5457–5463. 2017.PubMed/NCBI
|
|
32
|
Zhou J and Che Q: Poor expression of
microRNA-135b results in the inhibition of cisplatin resistance and
proliferation and induces the apoptosis of gastric cancer cells
through MST1-mediated MAPK signaling pathway. FASEB J.
33:3420–3436. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Turunen SP, Nandelstadh PV, Öhman T,
Gucciardo E, Seashore-Ludlow B, Martins B, Rantanen V, Li H,
Höpfner K, Östling P, et al: FGFR4 phosphorylates MST1 to confer
breast cancer cells resistance to MST1/2-dependent apoptosis. Cell
Death Differ. 26:2577–2593. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Buccitelli C and Selbach M: mRNAs,
proteins and the emerging principles of gene expression control.
Nat Rev Genet. 21:630–644. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kulkarni A, Chang MT, Vissers JHA, Dey A
and Harvey KF: The hippo pathway as a driver of select human
cancers. Trends Cancer. 6:781–796. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zheng Y and Pan D: The hippo signaling
pathway in development and disease. Dev Cell. 50:264–282. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tao Y, Cai F, Shan L, Jiang H, Ma L and Yu
Y: The hippo signaling pathway: An emerging anti-cancer drug
target. Discov Med. 24:7–18. 2017.PubMed/NCBI
|
|
38
|
Wu H, Zhang W, Wu Z, Liu Y, Shi Y, Gong J,
Shen W and Liu C: miR-29c-3p regulates DNMT3B and LATS1 methylation
to inhibit tumor progression in hepatocellular carcinoma. Cell
Death Dis. 10:482019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Han Q, Lin X, Zhang X, Jiang G, Zhang Y,
Miao Y, Rong X, Zheng X, Han Y, Han X, et al: WWC3 regulates the
Wnt and hippo pathways via dishevelled proteins and large tumour
suppressor 1, to suppress lung cancer invasion and metastasis. J
Pathol. 242:435–447. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fan F, He Z, Kong LL, Chen Q, Yuan Q,
Zhang S, Ye J, Liu H, Sun X, Geng J, et al: Pharmacological
targeting of kinases MST1 and MST2 augments tissue repair and
regeneration. Sci Transl Med. 8:352ra1082016. View Article : Google Scholar : PubMed/NCBI
|
